There are no generic Savella (milnacipran) products licensed for sale at this time. The medication is currently under the protection of a patent that prevents any generic versions from being manufactured and sold in the United States. The earliest predictable date that a generic version of Savella could become available is November 2021.
Is a Generic Version of Savella Available?
Savella™ (milnacipran hydrochloride) is a prescription medication approved for the treatment of fibromyalgia. It belongs to a group of medications known as serotonin-norepinephrine reuptake inhibitors (SNRIs).
Savella is made by Forest Laboratories, Inc. Currently, the medication is protected by a patent that prevents any generic versions from being sold in the United States.
When Will Generic Savella Be Available?
The first patent for Savella currently expires in November 2021. This is the earliest predictable date that a generic version of Savella could become available. However, other circumstances could come up to extend or shorten this time. This could include such things as lawsuits or patents for specific Savella uses. Once the patent expires, several companies likely will manufacture a generic Savella drug.
Is Milnacipran the Same as Generic Savella?
No -- milnacipran hydrochloride is the active ingredient in Savella, but is not a generic version of it. What can be confusing is that, oftentimes, the active ingredient of any drug is referred to as the "generic name." The generic name is different from a generic version of a medicine. In order for there to be a generic version of a medicine, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.